The expansion is part of LaunchWorks' response to meet the world's public health needs in disease detection and COVID-19 prevention.
FREMONT, CA: LaunchWorks, a contract and development organization serving the diagnostics industry, announced that it has expanded its filling capacity to produce diagnostic test kits with the introduction of new automation equipment at its Beverly, MA and Anjou, and Canada facilities.
The expansion is part of LaunchWorks' response to meet the world's public health needs in disease detection and COVID-19 prevention. LaunchWorks now has the capability and capacity to manufacture up to 500,000 microtubes or transport media tubes every week, thanks to the installation of modern filling automation equipment. The new automation also increases the efficiency of the process by increasing vial filling reproducibility.
"Our new suite of filling and capping machines will be easily redeployed for different formulations, allowing us to reduce the cost of manufacturing for customers," says Celine Barakat, General Manager, LaunchWorks. "This increased capacity reinforces our commitment to support the worlds changing needs during the pandemic, and, beyond that, the growing molecular diagnostics market."
LaunchWorks, which began as a division of Enzymatics in 2009 and now has two locations (Beverly, MA and Anjou, Canada), has grown over the past 12 years to become an ISO 13485-certified and FDA-registered corporation. Integreon Global purchased LaunchWorks in 2017 and has since expanded its service offerings, including launching a filing automation platform to help customers stay competitive. The response to the COVID-19 crisis has occupied a large portion of the company's recent efforts.